Acquiring Risk Assessment in Life Sciences: How Tricentis is Transforming Digital Validation

Austin, Texas, April 4, 2025 - (JCN Newswire) - The life sciences industry is rapidly evolving, with digital transformation (DX) at its core.
As regulatory oversight intensifies and the demand for faster software development grows, companies face significant challenges in accelerating innovation while ensuring compliance.
Tricentis, a leader in continuous testing for enterprises, offers comprehensive solutions to modernize computer system validation (CSV) and adopt a more efficient computer software assurance (CSA) model.
Traditionally, software validation in the life sciences industry has been complex and often reliant on paper-based procedures, hindering the progress of digitalization. However, the FDA's announcement of CSA guidelines in 2022 provided companies with a clear pathway to transition to risk-based validation. The CSA model aims to facilitate the automation and efficiency of the validation process while reducing the burden of documentation, all while ensuring compliance with regulations such as FDA 21 CFR Part 11.

Inquiry about this news
Contact Us Online